Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Proceeding of International Conference Health, Science And Technology (ICOHETECH)
Sudarsih, Dyah Ayu
Unknown Affiliation
Computer Science & IT Decision Sciences, Operations Research & Management Health Professions Industrial & Manufacturing Engineering Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
PROFILE OF CHEMOTHERAPY TREATMENT IN BREAST CANCER PATIENTS AT MOEWARDI GENERAL HOSPITAL IN 2025 Pratama, Kharisma Jayak; Luthfiyanti, Niken; Sudarsih, Dyah Ayu
Proceeding of the International Conference Health, Science And Technology (ICOHETECH) 2025: Proceeding of the 6th International Conference Health, Science And Technology (ICOHETECH)
Publisher : LPPM Universitas Duta Bangsa Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47701/04yg4q56

Abstract

Breast cancer is one of the most common types of cancer found in women, with a prevalence that continues to increase every year. Chemotherapy is one of the main therapies in the treatment of breast cancer, both as adjuvant therapy (after surgery) and neoadjuvant therapy (before surgery). Moewardi General Hospital, as a referral hospital in Central Java Province, provides chemotherapy treatment services for breast cancer patients with various drug regimens that have been proven effective. This study aims to analyze the chemotherapy treatment profile in breast cancer patients at Moewardi General Hospital in 2025. The data used in this study included the type of chemotherapy regimen, the number of patients using it, and the side effects experienced by patients. The results showed that the combination of Paclitaxel and Epirubicin was the main regimen used, with a percentage of patients reaching 30%. Common side effects include nausea, vomiting, fatigue, and a decrease in white blood cell count. Despite challenges in managing side effects, chemotherapy treatment at Moewardi General Hospital shows promising results with a high success rate. This study is expected to serve as a reference for improving the quality of breast cancer treatment at this hospital and provide insights for the development of chemotherapy therapy in the future.
Co-Authors Luthfiyanti, Niken Pratama, Kharisma Jayak